Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Application of Chronotherapy to Asthma
2019-004309-28Phase 4Unknown
- Sponsor
- Medicines Evaluation Unit
- Start
- Dec 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of beclometasone in allergic asthma and asthma (3 arms), sponsored by Medicines Evaluation Unit. Primary endpoint: Primary efficacy variables. Status: unknown.
02
Drugs
beclometasone
03
Conditions
allergic asthmaasthma
Beyond the preview
Go deeper on 2019-004309-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004309-28.